Retrolental fibroplasia definitions
| Word backwards | latnelorter aisalporbif |
|---|---|
| Part of speech | The word "retrolental fibroplasia" is a noun phrase. |
| Syllabic division | ret-ro-len-tal fi-bro-pla-sia. |
| Plural | The plural of the word retrolental fibroplasia is retrolental fibroplasias. |
| Total letters | 22 |
| Vogais (4) | e,o,a,i |
| Consonants (8) | r,t,l,n,f,b,p,s |
Retrolental fibroplasia is a condition that primarily affects premature infants, specifically those born before 31 weeks of gestation or weighing less than 1,500 grams at birth. This condition is also known as retinopathy of prematurity (ROP), and it occurs due to abnormal blood vessel development in the retina of the eye.
Symptoms of Retrolental Fibroplasia
Initially, infants with retrolental fibroplasia may not show any symptoms. However, as the condition progresses, some common signs may include abnormal eye movements, white pupils (leukocoria), sensitivity to light, and vision problems. In severe cases, retinal detachment can occur, leading to permanent vision loss.
Causes of Retrolental Fibroplasia
The main cause of retrolental fibroplasia is the exposure of premature infants to high levels of oxygen. In the mid-1900s, oxygen therapy was commonly used in neonatal intensive care units to support premature infants' respiratory function. However, it was later discovered that excessive oxygen levels could damage the developing blood vessels in the retina, leading to ROP.
Treatment and Prevention
Early detection and monitoring of ROP are essential to prevent vision loss in affected infants. Treatment options may include laser therapy to stop the abnormal blood vessel growth or surgery in cases of retinal detachment. Prevention strategies focus on carefully regulating oxygen levels in premature infants to avoid exposing them to excessive oxygen, thus reducing the risk of developing retrolental fibroplasia.
Retrolental fibroplasia remains a significant concern in neonatal care, highlighting the importance of specialized screening programs and close monitoring of at-risk infants. By understanding the causes, symptoms, and treatment options for ROP, healthcare providers can take proactive steps to protect infants' vision and quality of life.
Retrolental fibroplasia Examples
- The doctor diagnosed the premature infant with retrolental fibroplasia.
- Research is being conducted to better understand the causes of retrolental fibroplasia.
- Treatment options for retrolental fibroplasia are continuously being developed.
- Parents of infants at risk for retrolental fibroplasia should consult with a pediatric ophthalmologist.
- Education about retrolental fibroplasia is essential for healthcare professionals working with preterm babies.
- Oxygen therapy is a known risk factor for retrolental fibroplasia in premature newborns.
- Regular eye exams are recommended for children who had retrolental fibroplasia as infants.
- Retrolental fibroplasia is also known as retinopathy of prematurity.
- Prevention strategies for retrolental fibroplasia include controlling oxygen levels in premature infants.
- Families of children with retrolental fibroplasia may benefit from support groups.